GSK vs SCHW · P/E 13, $103.31B cap vs P/E 19, rev $13.55B
GlaxoSmithKline PLC ADR (GSK) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Richard Andrew Wurster C.F.A., CMT.
GSK does not have a complete income-statement cache yet.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the GSK and SCHW stock pages for the full models.
Not investment advice.